Origin & tradition
Green tea (Longjing, sencha, jasmine bases) has been a daily ritual beverage in China for over a millennium, valued for clarity, digestion, and vitality.
Eastern tradition · Premium Chinese Tea
The most-studied tea catechin, linked to lifespan and healthspan in models via AMPK, sirtuin and FOXO pathways.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Green tea (Longjing, sencha, jasmine bases) has been a daily ritual beverage in China for over a millennium, valued for clarity, digestion, and vitality.
Key active: Epigallocatechin gallate (EGCG).
EGCG and ECG act as mitohormetic compounds: transient complex-I inhibition activates AMPK (AAK-2), SIRT1 (SIR-2.1), NRF2 (SKN-1) and FOXO (DAF-16), raising stress resistance and reducing fat content in model organisms.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| LDL cholesterol oxidation | Decreases | Moderate | B |
| Body fat / BMI | Decreases | Minor | B |
| Blood pressure | Decreases | Minor | B |
| Cognitive function | Increases | Minor | C |
| Antioxidant markers (ORAC) | Increases | Moderate | B |
| Fasting blood glucose | Decreases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
3–4 cups brewed green tea provides ~200–400mg EGCG. Longjing and gyokuro have among the highest EGCG content. Avoid taking with milk (casein binds catechins).
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Strong preclinical + human trials across cardiometabolic and cognitive endpoints
EGCG and ECG act as mitohormetic compounds: transient complex-I inhibition activates AMPK (AAK-2), SIRT1 (SIR-2.1), NRF2 (SKN-1) and FOXO (DAF-16), raising stress resistance and reducing fat content in model organisms.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed, compound data from EMBL-EBI ChEMBL. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
An alkaloid from Chinese herbs (Coptis / Huang Lian) with human RCTs on metabolic health and an AMPK/sirtuin longevity rationale.
The diabetes drug at the center of the longevity debate — and the TAME trial designed to test aging itself.
A TCA-cycle metabolite that suppresses mTOR, co-factors DNA demethylation, and showed biological-age reduction in a 2023 human RCT.
“Southern ginseng,” a Chinese herb whose gypenosides activate AMPK — the metabolic longevity pathway.
Compare the evidence
Suppliers